The FDA has granted priority review to a new drug application (NDA) seeking the approval of sonrotoclax (BGB-11417; BeOne ...

After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres—the protective ...

When two cells "talk" to each other, they often do so through tiny channels called electrical synapses. Unlike chemical ...

To help Class 9 students score high marks in the Annual Exam 2026, we have compiled complete CBSE Class 9 Study Material 2025 ...

A live webcast, if recorded, of each presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that i ...

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical ...

Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating ...